{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:40:23Z","timestamp":1781660423504,"version":"3.54.5"},"reference-count":52,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2013,12,31]]},"DOI":"10.2217\/fon.13.141","type":"journal-article","created":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T12:16:22Z","timestamp":1386072982000},"page":"1883-1892","source":"Crossref","is-referenced-by-count":71,"title":["Mammalian Target of Rapamycin Inhibitor-Associated Stomatitis"],"prefix":"10.1080","volume":"9","author":[{"given":"Christine B","family":"Boers-Doets","sequence":"first","affiliation":[{"name":"Department of Clinical Oncology, Leiden University Medical Centre, PO Box 9600, 2300 RCLeiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith E","family":"Raber-Durlacher","sequence":"additional","affiliation":[{"name":"Department of Oral &amp; Maxillofacial Surgery, Academic Medical Center Amsterdam, Amsterdam, The Netherlands"},{"name":"Department of Periodontology, Academic Centre for Dentistry Amsterdam (ACTA), Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel S","family":"Treister","sequence":"additional","affiliation":[{"name":"Division of Oral Medicine &amp; Dentistry, Brigham &amp; Women\u2019s Hospital, Boston, MA, USA"},{"name":"Department of Oral Medicine, Infection &amp; Immunity, Harvard School of Dental Medicine, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel B","family":"Epstein","sequence":"additional","affiliation":[{"name":"Samuel Oschin Comprehensive Cancer Institute &amp; Division of Dentistry, Cedars-Sinai Medical Center, Los Angeles, CA, USA"},{"name":"Division of Otolaryngology\/Head &amp; Neck Surgery, City of Hope National Medical Center, Duarte, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anniek BP","family":"Arends","sequence":"additional","affiliation":[{"name":"Department of Periodontology, Academic Centre for Dentistry Amsterdam (ACTA), Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diede R","family":"Wiersma","sequence":"additional","affiliation":[{"name":"Department of Periodontology, Academic Centre for Dentistry Amsterdam (ACTA), Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh V","family":"Lalla","sequence":"additional","affiliation":[{"name":"Section of Oral Medicine, MC1605, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M","family":"Logan","sequence":"additional","affiliation":[{"name":"Oral Diagnostic Sciences, School of Dentistry, Health Sciences, University of Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nielka P","family":"van Erp","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Gelderblom","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Leiden University Medical Centre, PO Box 9600, 2300 RCLeiden, The Netherlands"},{"name":"Section of Oral Medicine, MC1605, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT, USA"},{"name":"Oral Diagnostic Sciences, School of Dentistry, Health Sciences, University of Adelaide, Australia"},{"name":"Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands"},{"name":"Department of Clinical Oncology, Leiden University Medical Centre, PO Box 9600, 2300 RCLeiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,12,3]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2062"},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI44145"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2010.499126"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2011.03.028"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp100531"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09290.x"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24696"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn066"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cden.2007.10.002"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1188\/11.CJON.E83-E89"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2011.08.009"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-010-0900-3"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0111"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.02.014"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2009-0178"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2012.11.008"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.6329"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon.11.57"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp504"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2010.01324.x"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp054630"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2008.00661.x"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2009.02.002"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200109150-00008"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02832.x"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1362"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20162"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-006-0054-5"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0"},{"issue":"1","key":"e_1_3_2_3_30_1","first-page":"S140","article-title":"The mIAS scale: a scale to measure mTOR inhibitor-associated stomatitis.","volume":"21","author":"Boers-Doets CB","year":"2013","unstructured":"Boers-Doets CB , LallaRV. The mIAS scale: a scale to measure mTOR inhibitor-associated stomatitis.Support. Care Cancer21(S1), S140 (2013).","journal-title":"Support. Care Cancer"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21816"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.11.037"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22484"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2008.2001"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2011.0124"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2010.01232.x"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2008-0120"},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.2"},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-012-1463-2"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-010-0837-6"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.7679"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers3022478"},{"key":"e_1_3_2_4_2_1","unstructured":"US FDA. (1-6-2007) FDA approval for temsirolimus. www.cancer.gov\/cancertopics\/druginfo\/fda-temsirolimus (Accessed 20 October 2010)"},{"key":"e_1_3_2_4_3_1","unstructured":"US FDA. (11-1-2010) Everolimus. www.fda.gov\/AboutFDA\/CentersOffices\/CDER\/ucm127799.htm (Accessed 20 October 2010)"},{"key":"e_1_3_2_4_4_1","unstructured":"National Cancer Institute. (4-9-2012) FDA approval for everolimus. www.cancer.gov\/cancertopics\/druginfo\/fda-everolimus (Accessed 22 October 2012)"},{"key":"e_1_3_2_4_5_1","unstructured":"National Cancer Institute. www.cancer.gov\/clinicaltrials (Accessed 12 September 2012)"},{"key":"e_1_3_2_4_6_1","unstructured":"Novartis Pharmaceuticals Corporation. (5-9-2011) Novartis drug Afinitor \u00ae gains EU approval to treat patients with advanced pancreatic neuroendocrine tumors. www.novartis.com\/newsroom\/media-releases\/en\/2011\/1543887.shtml. (Accessed 1 June 2011)"},{"key":"e_1_3_2_4_7_1","unstructured":"Pfizer. (2010) Full prescribing information temsirolimus (TORISEL). www.pfizerpro.com\/content\/showlabeling.asp?id=490 (Accessed 12 November 2010)"},{"key":"e_1_3_2_4_8_1","unstructured":"Novartis Pharmaceuticals Corporation. (2010) Full prescribing information everolimus (AFINITOR \u00ae ). www.pharma.us.novartis.com\/product\/pi\/pdf\/afinitor.pdf (Accessed 15 November 2010)"},{"key":"e_1_3_2_4_9_1","unstructured":"National Cancer Institute. (17-5-2012) Oral complications of chemotherapy and head\/neck radiation (PDQ \u00ae ) www.cancer.gov\/cancertopics\/pdq\/supportivecare\/oralcomplications\/HealthProfessional\/page5 (Accessed 22 October 2012)"},{"key":"e_1_3_2_4_10_1","unstructured":"National Cancer Institute. (9-8-2006) Common terminology criteria for adverse events v3.0 (CTCAE) www.eortc.be\/services\/doc\/ctc\/ctcaev3.pdf (Accessed 11 September 2009)"},{"key":"e_1_3_2_4_11_1","unstructured":"National Cancer Institute Cancer Therapy Evaluation Program. (15-12-2010) Common terminology criteria for adverse events and common toxicity criteria [v4.0]. http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_v40 (Accessed 1 June 2011)"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon.13.141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:43:02Z","timestamp":1719124982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon.13.141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,3]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12,31]]}},"alternative-id":["10.2217\/fon.13.141"],"URL":"https:\/\/doi.org\/10.2217\/fon.13.141","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,3]]}}}